Utah Medical Products ROE 2006-2020 | UTMD
Current and historical return on equity (ROE) values for Utah Medical Products (UTMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Utah Medical Products ROE for the three months ending March 31, 2020 was 14.72%.
| Utah Medical Products ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2020-03-31 | $0.02B | $0.09B | 15.63% |
| 2019-12-31 | $0.02B | $0.10B | 15.71% |
| 2019-09-30 | $0.01B | $0.10B | 15.14% |
| 2019-06-30 | $0.02B | $0.09B | 18.68% |
| 2019-03-31 | $0.02B | $0.09B | 19.26% |
| 2018-12-31 | $0.02B | $0.09B | 20.93% |
| 2018-09-30 | $0.01B | $0.09B | 14.41% |
| 2018-06-30 | $0.01B | $0.08B | 11.08% |
| 2018-03-31 | $0.01B | $0.08B | 11.29% |
| 2017-12-31 | $0.01B | $0.08B | 11.65% |
| 2017-09-30 | $0.02B | $0.08B | 20.00% |
| 2017-06-30 | $0.01B | $0.08B | 19.18% |
| 2017-03-31 | $0.01B | $0.07B | 18.18% |
| 2016-12-31 | $0.01B | $0.07B | 16.84% |
| 2016-09-30 | $0.01B | $0.07B | 16.78% |
| 2016-06-30 | $0.01B | $0.07B | 17.08% |
| 2016-03-31 | $0.01B | $0.07B | 17.27% |
| 2015-12-31 | $0.01B | $0.07B | 17.78% |
| 2015-09-30 | $0.01B | $0.07B | 18.11% |
| 2015-06-30 | $0.01B | $0.07B | 18.39% |
| 2015-03-31 | $0.01B | $0.06B | 18.60% |
| 2014-12-31 | $0.01B | $0.07B | 18.68% |
| 2014-09-30 | $0.01B | $0.06B | 18.97% |
| 2014-06-30 | $0.01B | $0.07B | 19.51% |
| 2014-03-31 | $0.01B | $0.06B | 20.51% |
| 2013-12-31 | $0.01B | $0.06B | 21.62% |
| 2013-09-30 | $0.01B | $0.06B | 20.75% |
| 2013-06-30 | $0.01B | $0.05B | 21.57% |
| 2013-03-31 | $0.01B | $0.05B | 20.30% |
| 2012-12-31 | $0.01B | $0.05B | 20.94% |
| 2012-09-30 | $0.01B | $0.05B | 22.10% |
| 2012-06-30 | $0.01B | $0.05B | 20.93% |
| 2012-03-31 | $0.01B | $0.05B | 21.69% |
| 2011-12-31 | $0.01B | $0.04B | 17.61% |
| 2011-09-30 | $0.01B | $0.04B | 17.95% |
| 2011-06-30 | $0.01B | $0.04B | 17.95% |
| 2011-03-31 | $0.01B | $0.04B | 15.48% |
| 2010-12-31 | $0.01B | $0.04B | 17.95% |
| 2010-09-30 | $0.01B | $0.04B | 17.95% |
| 2010-06-30 | $0.01B | $0.04B | 18.30% |
| 2010-03-31 | $0.01B | $0.04B | 21.33% |
| 2009-12-31 | $0.01B | $0.04B | 21.92% |
| 2009-09-30 | $0.01B | $0.04B | 22.38% |
| 2009-06-30 | $0.01B | $0.04B | 21.92% |
| 2009-03-31 | $0.01B | $0.04B | 21.33% |
| 2008-12-31 | $0.01B | $0.04B | 20.78% |
| 2008-09-30 | $0.01B | $0.04B | 20.25% |
| 2008-06-30 | $0.01B | $0.04B | 20.51% |
| 2008-03-31 | $0.01B | $0.04B | 20.92% |
| 2007-12-31 | $0.01B | $0.04B | 21.19% |
| 2007-09-30 | $0.01B | $0.04B | 21.62% |
| 2007-06-30 | $0.01B | $0.04B | 22.07% |
| 2007-03-31 | $0.01B | $0.04B | 22.54% |
| 2006-12-31 | $0.01B | $0.04B | 23.02% |
| 2006-09-30 | $0.01B | $0.04B | 23.53% |
| 2006-06-30 | $0.01B | $0.03B | 23.70% |
| 2006-03-31 | $0.01B | $0.03B | 23.70% |
| 2005-12-31 | $0.01B | $0.03B | 23.36% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.313B | $0.047B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $163.760B | 28.40 |
| Medtronic (MDT) | Ireland | $122.876B | 19.96 |
| Stryker (SYK) | United States | $68.133B | 22.11 |
| Boston Scientific (BSX) | United States | $48.348B | 22.73 |
| Baxter (BAX) | United States | $42.697B | 26.06 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.097B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $29.300B | 0.00 |
| Terumo (TRUMY) | Japan | $28.368B | 36.26 |
| ResMed (RMD) | United States | $27.881B | 44.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.546B | 15.44 |
| Sunny Optical Technology (SNPTF) | China | $20.292B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.095B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $13.860B | 63.09 |
| Insulet (PODD) | United States | $13.102B | 1298.06 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| Quidel (QDEL) | United States | $9.974B | 78.38 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $8.773B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $7.628B | 38.88 |
| Perrigo (PRGO) | Ireland | $7.488B | 13.40 |
| Hill-Rom Holdings (HRC) | United States | $7.452B | 21.01 |
| William Demant Holdings (WILYY) | Denmark | $6.296B | 0.00 |
| Canopy Growth (CGC) | Canada | $5.729B | 0.00 |
| Haemonetics (HAE) | United States | $4.502B | 27.04 |
| Neogen (NEOG) | United States | $4.099B | 69.43 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.005B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.905B | 0.00 |
| ICU Medical (ICUI) | United States | $3.833B | 27.96 |
| Agios Pharmaceuticals (AGIO) | United States | $3.779B | 0.00 |
| Envista Holdings (NVST) | United States | $3.229B | 0.00 |
| NuVasive (NUVA) | United States | $2.788B | 22.39 |
| TG Therapeutics (TGTX) | United States | $2.629B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.369B | 40.99 |
| AtriCure (ATRC) | United States | $1.744B | 0.00 |
| MacroGenics (MGNX) | United States | $1.548B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.417B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.377B | 0.00 |
| Aphria (APHA) | Canada | $1.233B | 0.00 |
| Cerus (CERS) | United States | $1.159B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.072B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $1.049B | 39.48 |
| Phibro Animal Health (PAHC) | United States | $1.015B | 20.24 |
| Vapotherm (VAPO) | United States | $0.971B | 0.00 |
| PetIQ (PETQ) | United States | $0.948B | 27.39 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.919B | 153.00 |
| InMode (INMD) | Israel | $0.916B | 19.36 |
| Zynex (ZYXI) | United States | $0.875B | 87.87 |
| OraSure Technologies (OSUR) | United States | $0.830B | 167.13 |
| Quanterix (QTRX) | United States | $0.762B | 0.00 |
| Omeros (OMER) | United States | $0.757B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.634B | 45.44 |
| VAREX IMAGING (VREX) | United States | $0.580B | 14.40 |
| BioLife Solutions (BLFS) | United States | $0.574B | 163.54 |
| Lantheus Holdings (LNTH) | United States | $0.572B | 11.50 |
| Surmodics (SRDX) | United States | $0.571B | 68.79 |
| LeMaitre Vascular (LMAT) | United States | $0.528B | 30.09 |
| Owens & Minor (OMI) | United States | $0.486B | 12.85 |
| Viemed Healthcare (VMD) | United States | $0.406B | 36.00 |
| Cytosorbents (CTSO) | United States | $0.369B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.335B | 0.00 |
| HEXO (HEXO) | $0.309B | 0.00 | |
| Organigram Holdings (OGI) | Canada | $0.271B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.223B | 123.67 |
| Female Health (VERU) | United States | $0.217B | 0.00 |
| Chimerix (CMRX) | United States | $0.193B | 0.00 |
| Surface Oncology (SURF) | United States | $0.176B | 0.00 |
| Bovie Medical (APYX) | United States | $0.164B | 0.00 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| Fonar (FONR) | United States | $0.136B | 12.03 |
| Rockwell Medical (RMTI) | United States | $0.127B | 0.00 |
| United Health Products (UEEC) | United States | $0.122B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.118B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.113B | 0.00 |
| Evolus (EOLS) | United States | $0.113B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.105B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.099B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.079B | 0.00 |
| Nephros (NEPH) | United States | $0.068B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.066B | 0.00 |
| United-Guardian (UG) | United States | $0.066B | 15.31 |
| Trinity Biotech (TRIB) | Ireland | $0.065B | 0.00 |
| Brainsway (BWAY) | Israel | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.037B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.028B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.020B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.016B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
